Whole-Genome Sequencing and Molecular Analysis of Ceftazidime-Avibactam-Resistant KPC-Producing
Klebsiella pneumoniae
carbapenem-resistant Enterobacterales
ceftazidime–avibactam
colonization
Journal
Antibiotics (Basel, Switzerland)
ISSN: 2079-6382
Titre abrégé: Antibiotics (Basel)
Pays: Switzerland
ID NLM: 101637404
Informations de publication
Date de publication:
03 Aug 2023
03 Aug 2023
Historique:
received:
23
06
2023
revised:
25
07
2023
accepted:
01
08
2023
medline:
26
8
2023
pubmed:
26
8
2023
entrez:
26
8
2023
Statut:
epublish
Résumé
Ceftazidime-avibactam (CAZ-AVI) is an active antibiotic combination of a β-lactam-β-lactamase inhibitor against carbapenemase-producing Enterobacterales. Reports of resistance to CAZ-AVI other than metallo-β-lactamases have increased in recent years. The aim of this study was to analyze KPC-
Identifiants
pubmed: 37627702
pii: antibiotics12081282
doi: 10.3390/antibiotics12081282
pmc: PMC10451778
pii:
doi:
Types de publication
Journal Article
Langues
eng
Subventions
Organisme : EU funding within the MUR PNRR Extended Partnership initiative on Emerging Infectious Diseases
ID : (Project no. PE00000007, INF-ACT)
Références
Bioinformatics. 2009 Jul 15;25(14):1754-60
pubmed: 19451168
Clin Microbiol Infect. 2015 May;21(5):470.e1-7
pubmed: 25684452
J Antimicrob Chemother. 2017 Jul 1;72(7):1930-1936
pubmed: 28333323
PLoS Pathog. 2022 Jul 11;18(7):e1010334
pubmed: 35816554
Int J Antimicrob Agents. 2020 Jul;56(1):106011
pubmed: 32417206
Virulence. 2017 May 19;8(4):403-416
pubmed: 27384881
Int J Antimicrob Agents. 2022 Jun;59(6):106594
pubmed: 35483624
Clin Microbiol Infect. 2013 May;19(5):451-6
pubmed: 22563800
Curr Infect Dis Rep. 2018 May 5;20(6):13
pubmed: 29730830
Antimicrob Agents Chemother. 2017 Nov 22;61(12):
pubmed: 29038260
J Glob Antimicrob Resist. 2021 Dec;27:132-141
pubmed: 34478880
Clin Infect Dis. 2012 Oct;55(7):943-50
pubmed: 22752516
J Antimicrob Chemother. 2021 Jan 19;76(2):355-361
pubmed: 33188415
Microbiol Spectr. 2022 Dec 21;10(6):e0373322
pubmed: 36445147
J Clin Microbiol. 2022 Mar 16;60(3):e0224521
pubmed: 35107303
Nat Microbiol. 2019 Nov;4(11):1919-1929
pubmed: 31358985
Nat Rev Microbiol. 2019 May;17(5):295-306
pubmed: 30837684
Folia Microbiol (Praha). 2021 Dec;66(6):879-896
pubmed: 34505209
Future Microbiol. 2014;9(9):1053-69
pubmed: 25340835
Clin Infect Dis. 2019 Jan 18;68(3):519-524
pubmed: 30020449
Aging Clin Exp Res. 2021 Mar;33(3):679-687
pubmed: 33428170
Antimicrob Agents Chemother. 2017 Feb 23;61(3):
pubmed: 28031201
Antibiotics (Basel). 2022 May 06;11(5):
pubmed: 35625273
PLoS One. 2014 Aug 11;9(8):e104984
pubmed: 25110940
Front Microbiol. 2019 Apr 02;10:542
pubmed: 31001209
J Antimicrob Chemother. 2016 Dec;71(12):3392-3399
pubmed: 27530752
J Antimicrob Chemother. 2015 Aug;70(8):2279-86
pubmed: 25957381
Clin Microbiol Infect. 2023 Apr;29(4):537.e1-537.e8
pubmed: 36414199
J Antimicrob Chemother. 2014 Jul;69(7):1972-80
pubmed: 24710025
Lancet Infect Dis. 2016 Feb;16(2):161-8
pubmed: 26603172
Antimicrob Agents Chemother. 2021 Aug 17;65(9):e0089021
pubmed: 34228551